白藜芦醇延缓视网膜缺血再灌注损伤中视网膜神经节细胞丢失并减轻胶质增生相关炎症
该研究在成年雄性Sprague Dawley大鼠右眼建立视网膜缺血再灌注损伤模型,通过腹腔注射白藜芦醇或对照缓冲液连续3天干预,评估其对视网膜神经节细胞凋亡、视网膜胶质增生和炎症的保护作用。结果显示白藜芦醇显著减少视网膜损伤和视网膜神经节细胞丢失,抑制Bax-caspase-3依赖性凋亡通路,并减轻胶质增生相关炎症,支持其作为青光眼潜在治疗策略。
要点
- 白藜芦醇减少缺血再灌注损伤后视网膜神经节细胞丢失和视网膜损伤。
- 白藜芦醇通过抑制Bax-caspase-3依赖性凋亡通路发挥抗凋亡作用。
- 白藜芦醇减轻视网膜胶质增生相关炎症,支持其用于青光眼治疗。
核心结论
- 白藜芦醇通过阻断Bax-caspase-3依赖性凋亡通路防止视网膜神经节细胞死亡,并抑制缺血再灌注损伤后视网膜胶质增生相关炎症。
研究设计与样本
- 在成年雄性Sprague Dawley大鼠中,通过将眼压升至110 mmHg持续60分钟诱导右眼视网膜缺血,左眼维持正常压力作为对照。
- 从缺血再灌注损伤前至损伤后连续3天腹腔注射白藜芦醇或对照缓冲液,评估并比较保护效果。
- 视网膜神经节细胞通过向 superiors colliculi 注射Fluoro-Gold进行逆行标记,凋亡通过TUNEL染色检测,Bax、Bcl-2和Caspase-3通过Western blotting和免疫染色检测,胶质增生通过抗GFAP抗体Western blotting和视网膜切片免疫染色评估。
主要发现
- 白藜芦醇治疗显著减少视网膜损伤,第7天HE染色显示组织结构的相对完整。
- 白藜芦醇治疗增加第14天Fluoro-Gold标记的视网膜神经节细胞。
- 白藜芦醇减少TUNEL染色,抑制凋亡相关蛋白Bax的早期上调表达,并减少后续cleaved caspase-3,但不影响Bcl-2水平。
- 白藜芦醇显著减轻缺血再灌注损伤模型中反应性胶质增生和相关炎症的联合反应,表现为早期促炎介质诱导和随后GFAP水平增加均被减弱。
临床怎么用
- 白藜芦醇可能作为青光眼的一种潜在治疗策略,通过抑制视网膜神经节细胞凋亡和胶质增生相关炎症发挥作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Resveratrol has been shown to enhance the survival of retinal ganglion cells (RGCs) following ischemia-reperfusion (I/R) injury for glaucoma. However, the precise mechanisms for resveratrol's protective effects are still unclear. The aim of this study is to determine whether resveratrol can inhibit RGC apoptosis, retinal gliosis, and inflammation, all of which are critical events in retinal degeneration following I/R injury. METHODS: Right retinal ischemia was induced in adult male Sprague Dawley rats by increasing intraocular pressure to 110 mm Hg for 60 minutes, and the left eyes maintained at normal pressure serve as the control. Intraperitoneal injection of resveratrol or control buffer was performed continuously for 3 days from pre- to post-I/R injury and the protective effects were evaluated and compared. RGCs were retrogradely labeled with Fluoro-Gold by injection into superior colliculi. Apoptosis was detected by TUNEL staining. Western blotting and immunostaining for Bax, Bcl-2, and Caspase-3 were used to explore the Bax-associated apoptotic pathway. Gliosis was assessed by western blotting and immunostaining of retinal cross sections with anti-glial fibrillary acidic protein (GFAP) antibodies. RESULTS: In this study, resveratrol treatment significantly reduced retinal damage and RGC loss as demonstrated by the relatively intact tissue structure in hematoxylin and eosin staining at day 7 and increased Fluoro-Gold labeling of RGCs at day 14, respectively. We found that resveratrol exhibited an anti-apoptotic effect as assessed by reduced TUNEL staining, inhibition of the early upregulated expression of the apoptosis-related protein Bax, and decreased subsequently cleaved caspase-3. However, it did not affect Bcl-2 levels. Moreover, in our I/R injury model, the combined response of reactive gliosis and related inflammation, which were demonstrated by an early induction of pro-inflammatory mediators and subsequently increased GFAP level, were significantly attenuated after resveratrol treatment. CONCLUSIONS: These results demonstrate that resveratrol can prevent RGC death by blocking the Bax-caspase-3-dependent apoptotic pathway and suppressed gliosis-related inflammation in the retina after I/R injury. Together these results support the use of resveratrol as a possible therapeutic strategy for glaucoma.
引用
- Luo H, Zhuang J, Hu P, et al. Resveratrol Delays Retinal Ganglion Cell Loss and Attenuates Gliosis-Related Inflammation From Ischemia-Reperfusion Injury. Invest Ophthalmol Vis Sci. 2018. PMID: 30073348. doi:10.1167/iovs.18-23806
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。